Compare BLUW & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLUW | GALT |
|---|---|---|
| Founded | 2024 | 2000 |
| Country | United States | United States |
| Employees | 2 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 334.1M | 297.0M |
| IPO Year | N/A | 2008 |
| Metric | BLUW | GALT |
|---|---|---|
| Price | $10.35 | $3.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 27.9K | ★ 524.5K |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.94 | $2.03 |
| 52 Week High | $10.41 | $7.13 |
| Indicator | BLUW | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 59.37 | 39.70 |
| Support Level | $10.24 | $2.75 |
| Resistance Level | $10.36 | $3.35 |
| Average True Range (ATR) | 0.01 | 0.38 |
| MACD | 0.00 | -0.17 |
| Stochastic Oscillator | 66.67 | 5.01 |
Blue Water Acquisition Corp III is a blank check company.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.